Page 106 - 《中国药房》2021年第4期
P. 106

UPLC-MS/MS 法同时测定人血浆中 5-FU 及其代谢产物 5-FUH2
        的浓度及应用                Δ


                                                            1 #
                                                   1
                         1
                                           1
               1*
        佟志强 ,吴东媛 ,张 娟 ,程梦飞 ,张 硕 ,董 梅 (1.哈尔滨医科大学附属肿瘤医院药学部,哈尔滨
                                  2
        150040;2.烟台毓璜顶医院药学部,山东 烟台 264000)
        中图分类号 R917;R735.3          文献标志码     A      文章编号     1001-0408(2021)04-0480-05
        DOI   10.6039/j.issn.1001-0408.2021.04.15
        摘   要   目的:建立同时测定人血浆中5-氟尿嘧啶(5-FU)及其代谢产物5-氟-5,6-二氢尿嘧啶(5-FUH2 )浓度的方法,并应用于临
        床。方法:血浆样品经乙酸乙酯二次萃取处理后,以5-溴尿嘧啶(5-Bru)为内标,采用超高效液相色谱-串联质谱技术(UPLC-MS/
        MS)测定。色谱柱为Acquity UPLC HSS T3,流动相为甲醇-水(30 ∶ 70,V/V),流速为0.3 mL/min,柱温为20 ℃,进样量为5 μL。采
        用电喷雾离子源,以多反应监测进行负离子扫描,毛细管电压为 1.5 kV,锥孔电压为 20 V,脱溶剂温度为 450 ℃,脱溶剂气流为
        850 L/h,锥孔气流速为50 L/h;用于定量分析的离子对分别为m/z 129.00→41.90(5-FU)、m/z 130.87→82.92(5-FUH2 )、m/z 189.00→
        42.10(5-Bru)。选择2020年8-10月哈尔滨医科大学附属肿瘤医院接受5-FU持续静脉滴注46 h为基础化疗方案治疗的晚期结直
        肠癌患者10例,测定其持续静脉滴注18~30 h时的5-FU稳态血药浓度及5-FUH2血药浓度,计算5-FU药-时曲线下面积(AUC)和
        5-FUH2/5-FU浓度比值。结果:5-FU、5-FUH2检测质量浓度的线性范围均为20~1 000 ng/mL(R 均大于0.990),定量下限均为20
                                                                                  2
        ng/mL;精密度试验的RSD均小于20%,相对误差在±10%范围内;提取回收率、基质效应均不影响待测物的测定。10例晚期结直
        肠癌患者中,5-FU 稳态血药浓度为 180.04~622.83 ng/mL,AUC 为 8.28~28.65 mg·h/L;5-FUH2 血药浓度为 336.48~948.43
        ng/mL;5-FUH2/5-FU浓度比值为0.93~4.21;10例患者的5-FU AUC存在约3~4倍的个体差异。结论:所建方法精密度、准确性均
        较好,灵敏度较高且操作简便,可用于晚期结直肠癌患者体内5-FU血药浓度的监测。
        关键词 超高效液相色谱-串联质谱法;5-氟尿嘧啶;5-氟-5,6-二氢尿嘧啶;血药浓度

        Simultaneous Determination of 5-FU and Its Metabolites 5-FUH2 in Human Plasma by UPLC-MS/MS and
        Application
        TONG Zhiqiang ,WU Dongyuan ,ZHANG Juan ,CHENG Mengfei ,ZHANG Shuo ,DONG Mei(1. Dept. of
                                                                                    1
                                                                     1
                                                    2
                       1
                                                                                                1
                                      1
        Pharmacy,Harbin Medical University Cancer Hospital,Harbin 150040,China;2. Dept. of Pharmacy,Yantai
        Yuhuangding Hospital,Shandong Yantai 264000,China)
        ABSTRACT    OBJECTIVE:To establish the method for simultaneous determination of 5-fluorouracil(5-FU)and its metabolites
        5-fluoro-5,6-dihydrouracil (5-FUH2 ) in human plasma,and apply it in the clinic. METHODS:After plasma samples were
        processed twice by ethyl acetate,UPLC-MS/MS method was adopted using 5-bromouracil (5-Bru) as internal standard. The
        determination was performed on Acquity UPLC HSS T3 column with mobile phase consisted of methanol-water(30 ∶ 70,V/V)at
        the flow rate of 0.3 mL/min. The column temperature was 20 ℃,and sample size was 5 μL. An electrospray ion source was used
        to carry out negative ion scanning with multiple reaction monitoring. The capillary voltage was 1.5 kV;the taper hole voltage was
        20 V;the desolvent temperature was 450 ℃;the desolvent air flow was 850 L/h;the cone hole gas velocity was 50 L/h. The ion
        transitions for quantitative analysis were m/z 129.00→41.90(5-FU),m/z 130.87→82.92(5-FUH2 ),m/z 189.00→42.10(5-Bru),
        respectively. From Aug. to Oct. 2020,10 patients with advanced colorectal cancer were treated with continuous intravenous drip of
        5-FU for 46 hours were collected from Harbin Medicinal University Cancer Hospital. Steady-state plasma concentration of 5-FU and
        plasma concentration of 5-FUH2 were determined at 18-30 h of continuous intravenous drip. The area under the curve(AUC)for
        5-FU and concentration ratio of 5-FUH2/5-FU were calculated. RESULTS:The linear range of 5-FU and 5-FUH2 were 20 to 1 000
        μg/mL(R >0.990). The quantification limits were 20 ng/mL. RSDs of precision test were all lower than 20%,and relative error
                2
        ranged ±10%. The extraction recovery and matrix effects didn’t affect the determination of substance to be measured. Among 10
        patients with advanced colorectal cancer,the steady-state concentration of 5-FU were 180.04-622.83 ng/mL,and AUC of 5-FU
        ranged from 8.28 to 28.65 mg·h/L. The concentration of 5-FUH2 ranged 336.48-948.43 ng/mL,and concentration ratio of 5-FUH2/
        5-FU ranged 0.93-4.21. AUC of 5-FU in 10 patients had about 3-4 fold individual differences. CONCLUSIONS:The established
                                                            method has good precision and accuracy,high sensitivity,and
            Δ 基金项目:黑龙江省卫生计生委科研课题(No.2016-095)
                                                            simple operation. It can be used for plasma monitoring of
            *硕士研究生。研究方向:抗肿瘤药物治疗药物监测。电话:
                                                            5-FU in patients with advanced colorectal cancer.
        0451-86298698。E-mail:1078408734@qq.com
                                                            KEYWORDS      UPLC-MS/MS; 5-FU; 5-FUH2; Plasma
            # 通信作者:主任药师,硕士生导师,博士。研究方向:医院药
                                                            concentration
        学。电话:0451-86298880。E-mail:13804567370@163.com
        ·480 ·  China Pharmacy 2021 Vol. 32 No. 4                                    中国药房    2021年第32卷第4期
   101   102   103   104   105   106   107   108   109   110   111